Integra LifeSciences IART Stock
Integra LifeSciences Price Chart
Integra LifeSciences IART Financial and Trading Overview
Integra LifeSciences stock price | 22.48 USD |
Previous Close | 40.71 USD |
Open | 40.77 USD |
Bid | 0 USD x 900 |
Ask | 0 USD x 800 |
Day's Range | 40.61 - 41.45 USD |
52 Week Range | 37.36 - 60.69 USD |
Volume | 709.54K USD |
Avg. Volume | 678.18K USD |
Market Cap | 3.38B USD |
Beta (5Y Monthly) | 1.160915 |
PE Ratio (TTM) | 20.33005 |
EPS (TTM) | -0.09 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 49.67 USD |
IART Valuation Measures
Enterprise Value | 4.62B USD |
Trailing P/E | 20.33005 |
Forward P/E | 11.369145 |
PEG Ratio (5 yr expected) | 2.12 |
Price/Sales (ttm) | 2.1641915 |
Price/Book (mrq) | 2.0178957 |
Enterprise Value/Revenue | 2.961 |
Enterprise Value/EBITDA | 11.85 |
Trading Information
Integra LifeSciences Stock Price History
Beta (5Y Monthly) | 1.160915 |
52-Week Change | -24.080% |
S&P500 52-Week Change | 20.43% |
52 Week High | 60.69 USD |
52 Week Low | 37.36 USD |
50-Day Moving Average | 49.28 USD |
200-Day Moving Average | 51.68 USD |
IART Share Statistics
Avg. Volume (3 month) | 678.18K USD |
Avg. Daily Volume (10-Days) | 684.53K USD |
Shares Outstanding | 81.9M |
Float | 70.81M |
Short Ratio | 2.38 |
% Held by Insiders | 13.08% |
% Held by Institutions | 94.59% |
Shares Short | 2.28M |
Short % of Float | 3.18% |
Short % of Shares Outstanding | 2.77% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 11.00% |
Operating Margin (ttm) | 17.32% |
Gross Margin | 62.89% |
EBITDA Margin | 24.98% |
Management Effectiveness
Return on Assets (ttm) | 4.56% |
Return on Equity (ttm) | 10.44% |
Income Statement
Revenue (ttm) | 1.56B USD |
Revenue Per Share (ttm) | 18.92 USD |
Quarterly Revenue Growth (yoy) | 1.09% |
Gross Profit (ttm) | 982.03M USD |
EBITDA | 390.26M USD |
Net Income Avi to Common (ttm) | 171.88M USD |
Diluted EPS (ttm) | 2.03 |
Quarterly Earnings Growth (yoy) | -26.40% |
Balance Sheet
Total Cash (mrq) | 323.03M USD |
Total Cash Per Share (mrq) | 3.94 USD |
Total Debt (mrq) | 1.61B USD |
Total Debt/Equity (mrq) | 96.32 USD |
Current Ratio (mrq) | 3.647 |
Book Value Per Share (mrq) | 20.452 |
Cash Flow Statement
Operating Cash Flow (ttm) | 246.28M USD |
Levered Free Cash Flow (ttm) | 212.63M USD |
Profile of Integra LifeSciences
Country | United States |
State | NJ |
City | Princeton |
Address | 1100 Campus Road |
ZIP | 08540 |
Phone | 609 275 0500 |
Website | https://www.integralife.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 3722 |
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Q&A For Integra LifeSciences Stock
What is a current IART stock price?
Integra LifeSciences IART stock price today per share is 22.48 USD.
How to purchase Integra LifeSciences stock?
You can buy IART shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Integra LifeSciences?
The stock symbol or ticker of Integra LifeSciences is IART.
Which industry does the Integra LifeSciences company belong to?
The Integra LifeSciences industry is Medical Devices.
How many shares does Integra LifeSciences have in circulation?
The max supply of Integra LifeSciences shares is 79.73M.
What is Integra LifeSciences Price to Earnings Ratio (PE Ratio)?
Integra LifeSciences PE Ratio is now.
What was Integra LifeSciences earnings per share over the trailing 12 months (TTM)?
Integra LifeSciences EPS is -0.09 USD over the trailing 12 months.
Which sector does the Integra LifeSciences company belong to?
The Integra LifeSciences sector is Healthcare.
Integra LifeSciences IART included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 18350.19 USD — |
-2.64
|
7.23B USD — | 18216.63 USD — | 18992.3 USD — | — - | 7.23B USD — |
NASDAQ Global Select Market Com NQGS | 8980.1 USD — |
-2.61
|
— — | 8914.08 USD — | 9291.63 USD — | — - | — — |
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
NASDAQ HealthCare IXHC | 993.66 USD — |
-1.66
|
— — | 990.15 USD — | 1016.8 USD — | — - | — — |
NASDAQ Composite Total Return I XCMP | 22440.37 USD — |
-2.64
|
— — | 22277.04 USD — | 23225.6 USD — | — - | — — |
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2905.88 USD — |
-2.19
|
— — | 2890.09 USD — | 2995.67 USD — | — - | — — |
- {{ link.label }} {{link}}